Compare AbCellera Biologics Inc (ABCL) vs Aterian Inc (ATER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Aterian Inc — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while Aterian Inc trades at $0.48 (market cap $5.32M). The key difference: AbCellera Biologics Inc is far larger — about 562× Aterian Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | ATER | |
|---|---|---|
Market Cap | $2.99B | $5.32M |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $1.39 |
52-Week Low | $2.78 | $0.36 |
Enterprise Value | $2.58B | $5.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →
